Lv5
1140 积分 2023-04-07 加入
Anti–PD-1 antibodies recognizing the membrane-proximal region are PD-1 agonists that can down-regulate inflammatory diseases
3个月前
已完结
Progress of antibody–drug conjugates (ADCs) targeting c-Met in cancer therapy; insights from clinical and preclinical studies
6个月前
已完结
Requirement of endogenous tumor necrosis factor/cachectin for recovery from experimental peritonitis
8个月前
已完结
Understanding the Specific Implications of Amino Acids in the Antibody Development
9个月前
已完结
Immunotherapies for hepatocellular carcinoma
10个月前
已完结
Hepatocellular carcinoma
11个月前
已完结
Antibody–drug conjugate as targeted therapeutics against hepatocellular carcinoma: preclinical studies and clinical relevance
11个月前
已完结
Preclinical studies of the bispecific MUC1xEGFR antibody drug conjugate M1231 in EGFR mutant NSCLC
1年前
已完结
Development of a novel antibody-drug conjugate targeting both CEACAM5 and CEACAM6
1年前
已完结
Antibody-drug conjugates of 7-ethyl-10-hydroxycamptothecin: Sacituzumab govitecan and labetuzumab govitecan
1年前
已完结
皖公网安备34019202002308
